Replies to post #223495 on Biotech Values

[dewophile]

I don't know if it ever will given the huge difference in cost vs generic viread. My guess is you probably need to have some underlying renal or bone issues (or develop them over time) to be eligible for TAF in most EU countries, which isn't likely to change any time soon.